COVID-19 is an emerging, rapidly evolving siituation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Notice of Changes to RFA-CA-15-022 and Pre-Application Webinar

The National Cancer Institute will hold a public Pre-Application webinar on Wednesday, January 13, 2016 at 12:00 p.m. (EST) for the Funding Opportunity Announcement (FOA) RFA-CA-15-022 entitled “Proteogenomic Translational Research Centers for Clinical Proteomic Tumor Analysis Consortium (U01).”

In addition, a new application due date (now May 11, 2016) has been issued for RFA-CA-15-022, and clarifications regarding the nature of documentation that an applicant must provide to document they will have proper access to clinical trial specimens for the proposed studies, are provided.

NCI staff members involved in this FOA will provide orientation and technical assistance to potential applicants by explaining the goals and objectives of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) initiative and answering questions from attendees about the CPTAC U01 Proteogenomic Translational Research Centers.

For information regarding the Notice of Changes to RFA-CA-15-022 and supporting documents, please visit NOT-CA-16-004 (http://grants.nih.gov/grants/guide/notice-files/NOT-CA-16-004.html).

For information regarding the Notice of Pre-Application Webinar and webinar coordinates, please visit NOT-CA-16-016 (http://grants.nih.gov/grants/guide/notice-files/NOT-CA-16-016.html)

Participation in this webinar, although encouraged, is optional and is not required for the submission of an application.